plerixafor glenmark 20 mg/ml solucion inyectable efg
glenmark arzneimittel gmbh - plerixafor - soluciÓn inyectable - 20 mg/ml inyectable 1,2 ml - plerixafor 20 mg - plerixafor
plerixafor accord
accord healthcare s.l.u. - plerixafor - multiple myeloma; hematopoietic stem cell transplantation - inmunoestimulantes, - adult patientsplerixafor accord is indicated in combination with granulocyte-colony stimulating factor (g-csf) to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in adult patients with lymphoma or multiple myeloma whose cells mobilise poorly (see section 4. paediatric patients (1 to less than 18 years)plerixafor accord is indicated in combination with g-csf to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in children with lymphoma or solid malignant tumours, either:- pre-emptively, when circulating stem cell count on the predicted day of collection after adequate mobilization with g-csf (with or without chemotherapy) is expected to be insufficient with regards to desired hematopoietic stem cells yield, or- who previously failed to collect sufficient haematopoietic stem cells (see section 4.
beyfortus
astrazeneca ab - nirsevimab - los sueros inmunes e inmunoglobulinas, - beyfortus is indicated for the prevention of respiratory syncytial virus (rsv) lower respiratory tract disease in neonates and infants during their first rsv season. beyfortus should be used in accordance with official recommendations.
plerixafor solución inyectable 24 mg/1,2 ml
msn labs chile s.p.a. - plerixafor - sin formulas
claforan 1 g polvo y disolvente para solucion inyectable iv
sanofi-aventis, s.a. - cefotaxima sodica - polvo y disolvente para soluciÓn inyectable - 1.000 mg - cefotaxima sodica 1000 mg - cefotaxima
claforan 1 g polvo y disolvente para solucion inyectable im
sanofi-aventis, s.a. - cefotaxima sodica - polvo y disolvente para soluciÓn inyectable - 1.000 mg - cefotaxima sodica 1000 mg - cefotaxima
claforan 2 g polvo y disolvente para solucion inyectable iv
sanofi-aventis, s.a. - cefotaxima sodica - polvo y disolvente para soluciÓn inyectable - 2.000 mg - cefotaxima sodica 2000 mg - cefotaxima
claforan 250 mg polvo y disolvente para solucion inyectable
sanofi-aventis, s.a. - cefotaxima sodica - polvo y disolvente para soluciÓn inyectable - 250 mg - cefotaxima sodica 250 mg - cefotaxima
claforan 500 mg polvo y disolvente para solucion inyectable
sanofi-aventis, s.a. - cefotaxima sodica - polvo y disolvente para soluciÓn inyectable - 500 mg - cefotaxima sodica 500 mg - cefotaxima
diaforin 4 mg comprimidos recubiertos con pelicula
brainpharma, s.l. - risperidona - comprimido recubierto con pelÍcula - 4 mg - risperidona 4 mg - risperidona